The pharmaceutical landscape for diabetes is evolving, and transdermal GLP-1 delivery systems represent a exciting advance. Unlike subcutaneous injections, this technique offers a less invasive way to provide GLP-1 https://cecilyzgmb205031.fitnell.com/82006385/glp-1-patches-a-innovative-approach-to-blood-sugar-management